2025
Contemporary approaches to treat people with hemophilia: what’s new and what’s not?
Valentino L, Santaella M, Carlson S, Recht M. Contemporary approaches to treat people with hemophilia: what’s new and what’s not? Research And Practice In Thrombosis And Haemostasis 2025, 9: 102696. PMID: 40084158, PMCID: PMC11905833, DOI: 10.1016/j.rpth.2025.102696.Peer-Reviewed Original ResearchComprehensive interdisciplinary careCare of peopleMiddle-income countriesBispecific monoclonal antibodyStandard of careHealth equityNonfactor productsFactor replacementHemophilia AJoint bleedsGenetic therapiesHemophiliaNormal hemostasisMonoclonal antibodiesAnticoagulant mechanismsTargeted inhibitorsUnaffected peersHaemophilia careBleedingNarrative reviewTreatmentTreatment of peopleAverage life expectancyInterdisciplinary careDiagnosis
2018
A Cost-Effectiveness Analysis of a Pediatric Operating Room in Uganda
Yap A, Muzira A, Cheung M, Healy J, Kakembo N, Kisa P, Cunningham D, Youngson G, Sekabira J, Yaesoubi R, Ozgediz D. A Cost-Effectiveness Analysis of a Pediatric Operating Room in Uganda. Surgery 2018, 164: 953-959. PMID: 29801729, PMCID: PMC6399742, DOI: 10.1016/j.surg.2018.03.023.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentChildChild, PreschoolCost-Benefit AnalysisDecision Making, OrganizationalDecision TreesFemaleHealth Services AccessibilityHealth Services Needs and DemandHumansInfantInfant, NewbornLife ExpectancyMaleModels, EconomicMonte Carlo MethodOperating RoomsQuality-Adjusted Life YearsSurgical Procedures, OperativeTreatment OutcomeUgandaConceptsIncremental cost-effectiveness ratioProbabilistic sensitivity analysesCost-effectiveness ratioPediatric operating roomDisability-adjusted life-year avertedStatistical life approachNet economic benefitsCost-effectiveness thresholdLife-year avertedCost-effectiveness analysisAverage life expectancySub-Saharan AfricaMonetary benefitsSensitivity analysisWorthwhile investmentEconomic benefitsOne-wayLow-income settingsTree templatePediatric surgical capacityLife approachFuture decisionsLife expectancyCostInvestment
1998
Promoting Informed Decision Making: Hormone Replacement Therapy
Bastian L, Couchman G, Rimer B, McBride C, Sutton L, Siegler I. Promoting Informed Decision Making: Hormone Replacement Therapy. Cancer Treatment And Research 1998, 97: 129-147. PMID: 9711414, DOI: 10.1007/978-0-585-30498-4_10.Peer-Reviewed Original ResearchConceptsHormonal replacement therapyReplacement therapyBreast cancerHormone replacement therapyRisk of cancerHRT useMenopausal symptomsMost gynecologistsHeart diseaseHigh riskNumber of womenAverage life expectancyCancerCancer issuesLife expectancyWomenMenopausePatientsTherapyRiskOsteoporosisGynecologistsSymptomsDiseasePhysicians
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply